Institute of Science in Society; Science, Society, Sustainability

Search the ISIS website

Google
  ISIS members area log in
     

Views and goods advertized are not necessarily endorsed by Science in Society or the Inst. of Science in Society.




ISIS Report - July 11, 2001

Cloning and ES Cells Both Biting the Dust

Failure of cloning from embryonic stem cells may spell the end of embryonic stem cell research and ‘therapeutic’ human cloning, Dr. Mae-Wan Ho reports.

"Cloning by nuclear transfer (NT) is an inefficient process in which most clones die before birth and survivors often display growth abnormalities" [1] This is now admitted by an international team of cloners who have examined mice cloned using donor nuclei from embryonic stem cells.

They found the epigenetic state – the state of gene imprinting and expression - of the ES cells "extremely unstable". Similar variations were found in the mice cloned from them. Many of the cloned animals survived to adulthood "despite widespread gene dysregulation" compared with controls. The researchers warn, "Our results indicate that even apparently healthy cloned animals can have gene expression abnormalities that are not severe enough to impede development to birth but that may cause subtle physiological abnormalities which could be difficult to detect."(p.97)

The research findings have implications not just for cloning but for ES cell research. The extreme instability of ES cells is not surprising, as such ‘somaclonal’ variations in cell culture is well known for both plant and animal cells, and we have drawn attention to this for ES cells [2]. Cell biologist Harry Rubin spent 20 years documenting the endless variation of mammallian cells arising in successive passages in culture, despite their supposed genetic uniformity [3].

The present authors state,

"Because ES cells are a potential in vitro source of many cell types for transplantation medicine, it will be important to assess whether the epigenetic state of human ES cells is as unstable as that of murine ES cells" ( ref. 1, p.97)

If human ES cells are just as unstable, it would be foolhardy to expect them not to cause problems in the transplant recipient.

It transpires that in the original draft of their paper, the authors had called for research to see if genetic instability in stem cells might "limit their use in clinical applications". But Jaenisch was allowed by the editor of Science to eliminate that sentence days before publication [4].

Now, the researchers are claiming that the variability may even be put to good use. For, if seemingly identical cell lines are subtly different from each other, then some may have particular promise for making "new brain cells for Parkinson's patients", and others may become cardiac tissue for heart attack patients. And "You may have to establish hundreds of lines to get the few you’d want to have," said John Gearhart, a pioneer stem cell researcher at Johns Hopkins University. Gearhart said he agreed with Jaenisch that the newly discovered genetic instability in embryonic stem cells probably will not interfere with the project of turning the cells into therapies.

This claim is fallacious, because somaclonal variation is uncontrollable and unpredictable. In other words, if human ES cells turn out to be just as unstable, there is no way to get useful stable lines out of them at all.

Another observation is that there is no significant correlation between abnormal fetal development and the abnormal expression of any single imprinted gene. "It is possible that the disturbance of placental and fetal growth is due to the cumulative action of many abnormally expressed genes which may have opposing influences on fetal growth.." (ref. 1, p.97)

They should have checked the ES cells for chromosomal abnormalities, which are also frequently found in cultured cells. In fact, largescale genomic instability may be present in addition to epigenetic instability. That should well and truly consign embryonic stem cells to the dustbin.

  1. Humpherys D, Eggan K, Akutsu H, Hochedlinger K, Rideout WM, Biniszkiewica D, Yanagimachi R and Jaenisch R. Epigenetic Instability in ES Cells and Cloned Mice. Science 2001, 293, 95-7.
  2. Ho MW and Cummins J. The unnecessary evil of ‘therapeutic’ human cloning. ISIS News 7/8, Feb. 2001, ISSN: 1474-1547 (print) ISSN: 1474-1814 (online) www.i-sis.org.uk
  3. See Rubin H. Cancer development: the rise of epigenetics. European Journal of Cancer 1992, 28, 1-2.
  4. "Clone Study casts doubt on Stem cells" By Rick Weiss, Washington Post, July 5, 2001,

printer friendly version

Join the I-SIS mailing list; enter your email address html asci

Recent Publications

The Rainbow and the Worm, The Physics of Organisms
The Rainbow and the Worm, The Physics of Organisms “Probably the Most Important Book for the Coming Scientific Revolution” Now in its Third Edition
Buy Now|More info

Food Futures Now
Food Futures Now: *Organic *Sustainable *Fossil Fuel Free How organic agriculture and localised food (and energy) systems can potentially compensate for all greenhouse gas emissions due to human activities and free us from fossil fuels
Buy Now|More info

Science in Society magazine The only radical science magazine on earth
Science in Society 40 OUT NOW! Order your copy from our online store.


GM Science Exposed
GM Science Exposed. A comprehensive dossier containing more than 160 fully referenced articles from the Science in Society archives.
Buy Now|More info

GMO Free: Exposing the Hazards of Biotechnology to Ensure the Integrity of our Food SupplyGMO Free: Exposing the Hazards of Biotechnology to Ensure the Integrity of our Food Supply
Buy Now|More info

I-SIS is a not-for-profit organisation, depending on donations, membership fees, subscriptions, and merchandise sales to continue its work. Find out more about membership here



The Institute of Science in Society, PO Box 51885, London NW2 9DH
telephone:
  [44 20 8452 2729]   [44 20 7272 5636]

Contact the Institute of Science in Society

MATERIAL ON THIS SITE MAY NOT BE REPRODUCED IN ANY FORM WITHOUT EXPLICIT PERMISSION. FOR PERMISSION, PLEASE CONTACT enquiries@i-sis.org.uk